Atsena Therapeutics IRD FDA Fast Track 01
March 13, 2025

Atsena Secures FDA Fast Track Designation for ATSN-201 to Treat X-Linked Retinoschisis

With no approved treatments for XLRS, another promising gene therapy enters the fray. Atsena Therapeutics (North Carolina, USA) announced that…

[Internal] Newsroom Researchers Develop Head Mounted Robotic System for Retinal Surgery (1)
February 24, 2025

Researchers Develop Head-Mounted Robotic System for Retinal Surgery

The retinal robot from the University of Utah’s John A. Moran Eye Center is capable of 1-micrometer movements. A team…

Discover our fascinating content at issuu

explore